FDA approves first oral medication for Ulcerative Colitis Vinay Singh singh1 Jun 2018 7:20 PM ISTThe Food and Drug Administration (FDA) approved Xeljanz (Signal Transducers and Activators of Transcription) to treat adults with moderate to severely...
Baricitinib -New Treatment for Moderate to severe RA Vinay Singh singh4 Jun 2018 7:30 PM ISTU.S. Food and Drug Administration (FDA) has approved the 2-mg dose of OLUMIANT®(baricitinib), a once-daily oral medication for the treatment of adults...
New drug effective for treatment of rheumatoid arthritis-The Lancet Vinay Singh singh24 Aug 2018 8:10 PM ISTA new drug was found safe and effective in treating patients with moderate to severe forms of rheumatoid arthritis who have shown an inadequate...
Novel treatment found for disfiguring cutaneous sarcoidosis Vinay Singh singh28 Dec 2018 7:25 PM ISTA new study published in NEJM has reported successful treatment of a patient with disfiguring sarcoidosis with a drug approved for rheumatoid...
FDA approves Upadacitinib for Moderate to Severe Rheumatoid Arthritis Deepanjana Sarkar20 Aug 2019 7:15 PM ISTFood and Drug Administration has approved JAK Kinase Inhibitor Drug, Upadacitinib for Moderate to Severe Rheumatoid Arthritis.The U.S. Food and Drug...
Baricitinib effective for treating moderate to severe atopic dermatitis, reveal clinical trial results Medha Baranwal Baranwal2 Sept 2019 7:30 PM ISTBaricitinib, an oral JAK inhibitor, has met its primary endpoint for the treatment of moderate to severe atopic dermatitis (AD) in adults, in...
Topical JAK Inhibitors found effective for treatment of Alopecia Vinay Singh singh21 Dec 2018 7:25 PM ISTTopical Janus kinase (JAK) inhibitors could be developed as a potential new treatment for alopecia areata (AA) and alternative to clobetasol...
